Endometriose unter Tamoxifentherapie

Fuith LC, L C Fuith, Lothar C. Fuith, Pflanzl W, W Pflanzl
Geburtshilfe und Frauenheilkunde · 1995 · vol. 55(06) , pp. 354–355 · doi:10.1055/s-2007-1023333 · PMID:7657147 · W2054221224
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher

Abstract

Tamoxifen is widely used in anti-oestrogen treatment of breast cancer. Recent reports show that, due to oestrogen-agonistic effects, tamoxifen is associated with endometrial carcinoma. We report on the case of a patient who developed endometriosis during tamoxifen treatment.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Breast Neoplasms Carcinoma, Ductal, Breast Endometriosis Ovarian Diseases Tamoxifen Breast Neoplasms Carcinoma, Ductal, Breast Chemotherapy, Adjuvant Endometriosis Endometriosis Female Humans Middle Aged Ovarian Diseases Ovarian Diseases Ovary Ovary Tamoxifen Tamoxifen

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-06T06:10:23.601157+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:13.665691+00:00
License: CC0 · commercial use OK